Cystic renal dysplasia as a leading sign of inherited metabolic disease
Glutaric acidemia type II and carnitine palmitoyltransferase type II deficiency are rare, but potentially treatable, inherited metabolic diseases. Hallmarks of the early onset form of both conditions are renal abnormalities and neonatal metabolic crisis. In this article, we report on two newborns with cystic renal dysplasia as a leading sign of these metabolic diseases. We focus on the clinical presentation and discuss the diagnostic tests and the available therapeutic options. We conclude that prenatal diagnosis of cystic renal dysplasia should alert the physician to the possibility of these metabolic diseases. This knowledge should prompt careful observation and, where necessary, early intervention during the postnatal period of catabolism.
KeywordsGlutaric acidemia type II Carnitine palmitoyltransferase type II deficiency Cystic renal dysplasia Metabolic crisis Emergency therapy
- 1.Frerman FE, Goodman SI (2001) Defects of electron transfer flavo-protein and electron transfer flavoprotein-ubiquinone oxidoreductase:glutaric acidemia type II. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease. McGraw Hill, New York, pp 2357–2365Google Scholar
- 8.Lehnert W, Wendel U, Lindenmaier S, Bohm N (1982) Multiple acyl-CoA dehydrogenation deficiency (glutaric aciduria type II), congenital polycystic kidneys, and symmetric warty dysplasia of the cerebral cortex in two brothers. I. Clinical, metabolical, and biochemical findings. Eur J Pediatr 139:56–59PubMedCrossRefGoogle Scholar
- 11.Bohm N, Uy J, Kiessling M, Lehnert W (1982) Multiple acyl-CoA dehydrogenation deficiency (glutaric aciduria type II), congenital polycystic kidneys, and symmetric warty dysplasia of the cerebral cortex in two newborn brothers. II. Morphology and pathogenesis. Eur J Pediatr 139:60–65PubMedCrossRefGoogle Scholar
- 19.Stanley CA (2000) Disorders of fatty acid oxidation. In: Fernandes J, Saudubray JM, Van den Berghe G (eds) (2000) Inborn metabolic diseases. Diagnosis and treatment, 3rd edn. Springer, Berlin, pp 140–150Google Scholar